Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$7.09 USD
-1.31 (-15.60%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $7.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
EBS 7.09 -1.31(-15.60%)
Will EBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EBS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EBS
Repligen (RGEN) Q2 Earnings Meet Estimates
Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Axsome (AXSM) Down 6.1% Since Last Earnings Report: Can It Rebound?
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates
Other News for EBS
Emergent Biosolutions (EBS) Receives a Buy from Benchmark Co.
Emergent BioSolutions rises 34.3%
Emergent BioSolutions falls -38.5%
Disney, Airbnb dip despite quarterly beats: Morning Buzz
Emergent BioSolutions falls -38.1%